BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Biovista

Biovista logo

Website
https://www.biovista.com/
Founded
1999

Technologies

AI Companies (Drug Discovery)

Biovista delivers custom drug repositioning, drug de-risking and clinical hold solutions for the Biopharma Industry. Biovista also develops powerful platform technologies for Life science and Biotechnology companies. Biovista has an ongoing R&D program to develop new and improve existing products and services.

rare diseases

R&D Platform

Drug repositioning specialist Biovista Inc. has tapped Hewlett Packard Enterprise Co. (HPE) to add greater computing power to Project Prodigy, a personalized medicine platform that leverages artificial intelligence (AI) to help doctors identify novel drugs for hard-to-treat patients.This proprietary platform, called COSS™ (Clinical Outcomes Search Space), supports Biovista scientists in uncovering non-obvious correlations between drugs, molecular targets, pathways, adverse events and diseases and constructing evidence-based biological plausibility rationale on a systematic and highly predictable basis.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.